Logo image of EXE

EXPAND ENERGY CORP (EXE) Stock Fundamental Analysis

NASDAQ:EXE - Nasdaq - US1651677353 - Common Stock - Currency: USD

103.01  +0.77 (+0.75%)

After market: 103.01 0 (0%)

Fundamental Rating

3

Taking everything into account, EXE scores 3 out of 10 in our fundamental rating. EXE was compared to 212 industry peers in the Oil, Gas & Consumable Fuels industry. EXE has a bad profitability rating. Also its financial health evaluation is rather negative. EXE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

EXE had positive earnings in the past year.
In the past year EXE had a positive cash flow from operations.
In multiple years EXE reported negative net income over the last 5 years.
In the past 5 years EXE always reported a positive cash flow from operatings.
EXE Yearly Net Income VS EBIT VS OCF VS FCFEXE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

EXE has a worse Return On Assets (-2.56%) than 75.94% of its industry peers.
EXE's Return On Equity of -4.06% is on the low side compared to the rest of the industry. EXE is outperformed by 72.64% of its industry peers.
Industry RankSector Rank
ROA -2.56%
ROE -4.06%
ROIC N/A
ROA(3y)15.25%
ROA(5y)-8.99%
ROE(3y)23.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EXE Yearly ROA, ROE, ROICEXE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

With a decent Gross Margin value of 65.49%, EXE is doing good in the industry, outperforming 70.75% of the companies in the same industry.
EXE's Gross Margin has declined in the last couple of years.
EXE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-3.59%
EXE Yearly Profit, Operating, Gross MarginsEXE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

1

2. Health

2.1 Basic Checks

EXE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EXE has been increased compared to 1 year ago.
Compared to 5 years ago, EXE has more shares outstanding
EXE has a worse debt/assets ratio than last year.
EXE Yearly Shares OutstandingEXE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
EXE Yearly Total Debt VS Total AssetsEXE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

EXE has an Altman-Z score of 1.59. This is a bad value and indicates that EXE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of EXE (1.59) is comparable to the rest of the industry.
The Debt to FCF ratio of EXE is 710.00, which is on the high side as it means it would take EXE, 710.00 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 710.00, EXE is not doing good in the industry: 61.32% of the companies in the same industry are doing better.
EXE has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.30, EXE is in the better half of the industry, outperforming 62.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 710
Altman-Z 1.59
ROIC/WACCN/A
WACC9.96%
EXE Yearly LT Debt VS Equity VS FCFEXE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B 15B

2.3 Liquidity

A Current Ratio of 0.64 indicates that EXE may have some problems paying its short term obligations.
EXE has a Current ratio of 0.64. This is in the lower half of the industry: EXE underperforms 78.77% of its industry peers.
EXE has a Quick Ratio of 0.64. This is a bad value and indicates that EXE is not financially healthy enough and could expect problems in meeting its short term obligations.
EXE has a worse Quick ratio (0.64) than 73.58% of its industry peers.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.64
EXE Yearly Current Assets VS Current LiabilitesEXE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

EXE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -73.93%.
The earnings per share for EXE have been decreasing by -60.58% on average. This is quite bad
EXE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -46.03%.
EXE shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -13.27% yearly.
EPS 1Y (TTM)-73.93%
EPS 3Y-60.58%
EPS 5YN/A
EPS Q2Q%-58.02%
Revenue 1Y (TTM)-46.03%
Revenue growth 3Y-10.19%
Revenue growth 5Y-13.27%
Sales Q2Q%10.61%

3.2 Future

Based on estimates for the next years, EXE will show a very strong growth in Earnings Per Share. The EPS will grow by 64.72% on average per year.
The Revenue is expected to grow by 43.98% on average over the next years. This is a very strong growth
EPS Next Y530.88%
EPS Next 2Y187.47%
EPS Next 3Y91.67%
EPS Next 5Y64.72%
Revenue Next Year163.13%
Revenue Next 2Y70.44%
Revenue Next 3Y43.98%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EXE Yearly Revenue VS EstimatesEXE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B 20B
EXE Yearly EPS VS EstimatesEXE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15 20

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 80.48 indicates a quite expensive valuation of EXE.
Based on the Price/Earnings ratio, EXE is valued a bit more expensive than the industry average as 70.28% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 28.33. EXE is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 12.76, the valuation of EXE can be described as correct.
The rest of the industry has a similar Price/Forward Earnings ratio as EXE.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.37, EXE is valued a bit cheaper.
Industry RankSector Rank
PE 80.48
Fwd PE 12.76
EXE Price Earnings VS Forward Price EarningsEXE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

EXE's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. EXE is more expensive than 75.00% of the companies in the same industry.
EXE's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 2996.31
EV/EBITDA 32.23
EXE Per share dataEXE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

EXE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXE's earnings are expected to grow with 91.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.15
PEG (5Y)N/A
EPS Next 2Y187.47%
EPS Next 3Y91.67%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.16%, EXE has a reasonable but not impressive dividend return.
EXE's Dividend Yield is slightly below the industry average, which is at 7.41.
Compared to an average S&P500 Dividend Yield of 2.51, EXE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.16%

5.2 History

The dividend of EXE decreases each year by -29.99%.
EXE has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-29.99%
Div Incr YearsN/A
Div Non Decr YearsN/A
EXE Yearly Dividends per shareEXE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

The earnings of EXE are negative and hence is the payout ratio. EXE will probably not be able to sustain this dividend level.
DP-54.34%
EPS Next 2Y187.47%
EPS Next 3Y91.67%
EXE Yearly Income VS Free CF VS DividendEXE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

EXPAND ENERGY CORP

NASDAQ:EXE (4/22/2025, 8:01:18 PM)

After market: 103.01 0 (0%)

103.01

+0.77 (+0.75%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners93.44%
Inst Owner ChangeN/A
Ins Owners2.79%
Ins Owner Change19.07%
Market Cap23.97B
Analysts80
Price Target126.22 (22.53%)
Short Float %5.62%
Short Ratio3.76
Dividend
Industry RankSector Rank
Dividend Yield 2.16%
Yearly Dividend2.14
Dividend Growth(5Y)-29.99%
DP-54.34%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date03-11 2025-03-11 (0.575)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)185.37%
Min EPS beat(2)14.16%
Max EPS beat(2)356.59%
EPS beat(4)3
Avg EPS beat(4)207.05%
Min EPS beat(4)-6.54%
Max EPS beat(4)464.01%
EPS beat(8)7
Avg EPS beat(8)130.63%
EPS beat(12)11
Avg EPS beat(12)95.93%
EPS beat(16)14
Avg EPS beat(16)118.67%
Revenue beat(2)1
Avg Revenue beat(2)-3.19%
Min Revenue beat(2)-8.38%
Max Revenue beat(2)1.99%
Revenue beat(4)1
Avg Revenue beat(4)-12.04%
Min Revenue beat(4)-36.48%
Max Revenue beat(4)1.99%
Revenue beat(8)5
Avg Revenue beat(8)10.91%
Revenue beat(12)8
Avg Revenue beat(12)23.64%
Revenue beat(16)10
Avg Revenue beat(16)24.08%
PT rev (1m)4.96%
PT rev (3m)N/A
EPS NQ rev (1m)11.28%
EPS NQ rev (3m)70.04%
EPS NY rev (1m)58.34%
EPS NY rev (3m)94.12%
Revenue NQ rev (1m)7.67%
Revenue NQ rev (3m)14.75%
Revenue NY rev (1m)16.58%
Revenue NY rev (3m)22%
Valuation
Industry RankSector Rank
PE 80.48
Fwd PE 12.76
P/S 5.71
P/FCF 2996.31
P/OCF 15.32
P/B 1.36
P/tB 1.36
EV/EBITDA 32.23
EPS(TTM)1.28
EY1.24%
EPS(NY)8.08
Fwd EY7.84%
FCF(TTM)0.03
FCFY0.03%
OCF(TTM)6.73
OCFY6.53%
SpS18.03
BVpS75.48
TBVpS75.48
PEG (NY)0.15
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.56%
ROE -4.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.49%
FCFM 0.19%
ROA(3y)15.25%
ROA(5y)-8.99%
ROE(3y)23.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-3.59%
F-Score2
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 710
Debt/EBITDA 5.81
Cap/Depr 90.05%
Cap/Sales 37.11%
Interest Coverage N/A
Cash Conversion 171.98%
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.64
Altman-Z 1.59
F-Score2
WACC9.96%
ROIC/WACCN/A
Cap/Depr(3y)104.61%
Cap/Depr(5y)98.42%
Cap/Sales(3y)25.52%
Cap/Sales(5y)22.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.93%
EPS 3Y-60.58%
EPS 5YN/A
EPS Q2Q%-58.02%
EPS Next Y530.88%
EPS Next 2Y187.47%
EPS Next 3Y91.67%
EPS Next 5Y64.72%
Revenue 1Y (TTM)-46.03%
Revenue growth 3Y-10.19%
Revenue growth 5Y-13.27%
Sales Q2Q%10.61%
Revenue Next Year163.13%
Revenue Next 2Y70.44%
Revenue Next 3Y43.98%
Revenue Next 5YN/A
EBIT growth 1Y-137.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5223.9%
EBIT Next 3Y291.56%
EBIT Next 5Y177.56%
FCF growth 1Y-98.55%
FCF growth 3Y-80.34%
FCF growth 5YN/A
OCF growth 1Y-34.24%
OCF growth 3Y-4.34%
OCF growth 5Y-0.73%